BPC 157 · 10 mg

from US$80.00

BPC 157 is a synthetic peptide studied for tendon biology, tissue repair and gastrointestinal protection in preclinical models.

Complimentary BAC water with every order.

Format:
Vial:

BPC 157 is a synthetic peptide studied for tendon biology, tissue repair and gastrointestinal protection in preclinical models.

Complimentary BAC water with every order.

Packaging & supply options

Your format, your way.

The same research peptide, with a choice of accessories and supply formats. Here’s what each option includes.

BAC water

Vial kit

Lyophilised peptide vial with separately packaged, complimentary BAC water.

BAC water + syringes

Syringe kit

Lyophilised peptide vial, BAC water and syringes.

BAC water + pen

Injection pen kit

Lyophilised peptide vial, BAC water and an injection pen.

Pen + pen needles

Reconstituted pen

VIETNAM ONLY

Peptide solution supplied in a pen at the stated concentration, with pen needles.

For laboratory research only. Not for human or veterinary use.

Everform Pharma · Compound profile

BPC 157.
A closer look at repair.

Explore tendon biology, vascular signalling and the research behind this widely discussed peptide.

Emerald exercise mat and curved ivory woven strap beside emerald glass on sunlit travertine, symbolising movement and connective-tissue research.
Conceptual illustration of movement and connective-tissue research.

What is BPC 157?

BPC 157 is a synthetic peptide made from 15 amino acids. Its name is associated with “body protection compound”, and it has been investigated in experimental models of tissue injury and repair. Tendon research is one of the clearest starting points for understanding its scientific profile. [1] [2]

Researchers are interested in how cells move, survive stress and organise the environment around an injury. These questions connect BPC 157 with tendon biology, blood-vessel signalling and gastrointestinal research.

How does BPC 157 work?

There is no single established human mechanism that explains every claim made about BPC 157. Instead, laboratory studies examine several related processes.

In rat tendon-cell and tissue experiments, BPC 157 increased cell migration and outgrowth from tendon explants. The researchers linked these responses to FAK–paxillin signalling, which helps coordinate cell adhesion and movement. [1]

A separate study investigated VEGFR2, a receptor involved in blood-vessel signalling, using endothelial cells and animal models. This work connects BPC 157 with research into vascular responses after injury. [3]

CELL MOVEMENT

Examining how tendon-related cells migrate, spread and respond to stress.

VASCULAR SIGNALLING

Exploring receptor pathways involved in blood-vessel formation and tissue blood supply.

Main research areas

These themes explain why BPC 157 appears so often in discussions of tissue repair. The type of study remains essential to interpreting each finding.

Research areaWhat studies examine
Tendon biologyCell movement, tissue organisation and mechanical recovery in rat tendon experiments. [1] [2]
Vascular responsesVEGFR2 activity and angiogenesis in endothelial-cell and animal models. [3]
Gastrointestinal tissueBlood flow and tissue injury in experimental rat colitis and intestinal ischaemia models. [4]
Joint symptomsPatient-reported knee-pain changes in a small retrospective human study. [5]

These are research topics, not guaranteed benefits or treatment indications for an Everform product.

What published findings show

Cell and tissue studies: Chang and colleagues reported greater tendon-explant outgrowth and tendon-fibroblast migration, with improved cell survival under an oxidative-stress condition. Cell proliferation was not directly increased in their assay. These distinctions help explain what the experiment actually measured. [1]

Animal tendon research: A study of surgically injured Achilles tendons in rats reported improvements in mechanical, functional and tissue-structure measures. It provides a preclinical basis for further investigation, rather than a human recovery timetable. [2]

Gastrointestinal research: Duzel and colleagues examined BPC 157 in rat models involving colonic blood-flow disruption and injury. The reported vascular and tissue responses are specific to those experimental conditions; they are not proof of treatment benefit for human digestive disorders. [4]

Human observations: A retrospective knee-pain report included a BPC-157-only subgroup of 12 patients; 11 reported improvement. There was no randomised control group, and follow-up relied on patient reports without standardised functional outcome measures. The findings are exploratory and cannot establish the peptide’s effectiveness or safety. [5]

Animal healing findings and patient-reported symptom changes answer different questions. Neither demonstrates that an Everform research vial or pen repairs a human tendon, ligament or joint.

The Everform product, at a glance

CompoundBPC 157

Labelled vial amount20 mg

Base formatLyophilised peptide powder

Supply optionsSee the format guide above

Everform Pharma is based in Da Nang, Vietnam. Use the product selector to choose an available supply format. Complimentary BAC water is included with every order.

Explore Your format, your way →

Check the label for the full REF, expiry date and storage conditions. The security sticker on the transport package repeats the product identifier and should match the vial or pen inside. Match the full REF to the relevant documentation.

Identity, chromatographic purity and measured peptide content answer different questions on a COA. A purity percentage alone does not establish the amount of peptide per vial.

Explore our label and COA guide →

Common questions

What does “pentadecapeptide” mean?

It means a peptide containing 15 amino acids. It describes molecular length, not a dose or an indication of potency. [1]

Do human cells in a laboratory count as a human clinical trial?

No. A cell-culture experiment examines cells outside the body. Even when those cells are human-derived, the result does not establish a treatment outcome in people.

Does “20 mg” describe a dose?

No. It is the labelled amount of peptide in the vial, not a recommended dose or an administration instruction.

Do the studies establish a recovery timeline?

No. The studies discussed use different models and outcome measures. Their findings cannot be converted into a reliable number of days for a person’s tendon or joint recovery.

Where should I check storage and identification?

Follow the conditions on your actual product label. Confirm that the package security sticker matches the vial or pen, and use the full REF when requesting the matching documentation.

References

[1] Chang et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology, 2011.

[2] Staresinic et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. Journal of Orthopaedic Research, 2003.

[3] Hsieh et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of Molecular Medicine, 2017.

[4] Duzel et al. Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights. World Journal of Gastroenterology, 2017.

[5] Lee and Padgett. Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain. Alternative Therapies in Health and Medicine, 2021.

Everform Pharma · Da Nang, Vietnam
Educational product information.
For laboratory research only.
Not for human or veterinary use.